CT guided high dose brachytherapy can be successfully implemented in a cancer centre achieving good levels of local control and overall survival. Node positivity on original MRI is predictive for recurrence.A complete response on week 5 MRI predicts for excellent long term pelvic control.
follow up of 4.5 years (range 1.2-6.5), 78% of women were free of disease and 21% had evidence of tumour progression or relapse. All items exhibited good compliance with no missing values except those regarding sexual function that were missed in 37.5% of patients. The 92.5% of women judged their overall health and QoL good. In particular all patients with no evidence of tumour relapse judged a favorable QoL, and only 36% of patients with progression disease judged their QoL poor. Table 1 shows the answers considering tumour type and treatment modality. We calculated the Chi-Square Test to compare treatment modalities (operated or non-operated patients; pelvic external beam radiotherapy ± brachytherapy) and tumour sites (cervical or endometrial) for the various items. For all the items of Table 1 , we did find a trend just below the threshold of significance (p=0.06-0.08).
Conclusions:
From our analysis, it emerged a good QoL for the whole series with similar percentages for the different tumour types and treatment modalities. The presence of tumour progression reduced QoL. We found that patients treated for cervical cancer complained of higher incidence of disuria and bladder incontinence. No patient complained of severe symptoms related to gastro-intestinal dysfunction or faecal incontinence. 
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